(Q47965876)

7 February 2018

review article

1 reference

title

Matrix metalloproteinase inhibitors in arthritis (English)

1 reference

7 February 2018

author name string

Bottomley KM

series ordinal

1

1 reference

7 February 2018

Johnson WH

series ordinal

2

1 reference

7 February 2018

Walter DS

series ordinal

3

1 reference

7 February 2018

publication date

1 April 1998

1 reference

7 February 2018

Journal of Enzyme Inhibition and Medicinal Chemistry

published in

1 reference

7 February 2018

volume

13

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

79-101

1 reference

7 February 2018

Evolutionary families of metallopeptidases

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Furin-dependent intracellular activation of the human stromelysin-3 zymogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

A matrix metalloproteinase expressed on the surface of invasive tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Matrix metalloproteinases and the development of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Collagenase inhibitors: their design and potential therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Synthesis of novel N-phosphonoalkyl dipeptide inhibitors of human collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

1.56 A structure of mature truncated human fibroblast collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369809035829

10.3109/14756369809035829

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018